Bill Status of SB 2996   100th General Assembly

Short Description:  ELEVATED BLOOD LEAD LEVEL

Senate Sponsors
Sen. Jacqueline Y. Collins-Mattie Hunter, Kimberly A. Lightford-Emil Jones, III-Iris Y. Martinez, Cristina Castro and Thomas Cullerton

House Sponsors
(Rep. Kathleen Willis-Litesa E. Wallace-Nick Sauer-Robyn Gabel-Laura Fine, Stephanie A. Kifowit, Lou Lang, Nicholas K Smith and Deb Conroy)


Last Action  View All Actions

DateChamber Action
  8/3/2018SenatePublic Act . . . . . . . . . 100-0723

Statutes Amended In Order of Appearance
410 ILCS 45/1from Ch. 111 1/2, par. 1301

Synopsis As Introduced
Amends the Lead Poisoning Prevention Act. Makes a technical change in a Section concerning the short title.

Senate Committee Amendment No. 2
Deletes reference to:
410 ILCS 45/1
Adds reference to:
410 ILCS 45/2from Ch. 111 1/2, par. 1302
410 ILCS 45/7from Ch. 111 1/2, par. 1307
410 ILCS 45/14from Ch. 111 1/2, par. 1314

Replaces everything after the enacting clause. Amends the Lead Poisoning Prevention Act. Provides that "elevated blood lead level" means a blood lead level in excess of the limits (currently, those considered within the permissible limits) established under State rules (currently, State and federal rules). Provides that "lead poisoning" means having an elevated blood lead level (rather than the condition of having blood lead levels in excess of those considered safe under State and federal rules). Provides that no later than 180 days after the effective date of the amendatory Act, the Department of Public Health shall submit proposed amended rules to the Joint Committee on Administrative Rules to update: the definition of elevated blood lead level to be in accordance with the most recent childhood blood lead level reference value from the federal Centers for Disease Control and Prevention; the current requirements for the inspection of regulated facilities occupied by children based on the updated definition of elevated blood lead level or the history of lead hazards; and any other existing rules that will assist the Department in its efforts to prevent, reduce, or mitigate the negative impact of instances of lead poisoning among children. Provides that results identifying an elevated blood lead level (rather than in excess of the permissible limits set forth in rules adopted by the Department) shall be reported to the Department within 48 hours of receipt of verification. Provides that directors of clinical laboratories must report to the Department, within 48 hours of receipt of verification, all blood lead analyses equal to or above an elevated blood lead level (rather than above permissible limits set forth in rule) performed in their facility. Provides that all blood lead levels less than an elevated blood lead level (rather than the permissible limits set forth in rule) must be reported to the Department in accordance with rules adopted by the Department.

Actions 
DateChamber Action
  2/15/2018SenateFiled with Secretary by Sen. Jacqueline Y. Collins
  2/15/2018SenateFirst Reading
  2/15/2018SenateReferred to Assignments
  3/1/2018SenateAssigned to Public Health
  3/1/2018SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Jacqueline Y. Collins
  3/1/2018SenateSenate Committee Amendment No. 1 Referred to Assignments
  3/13/2018SenateSenate Committee Amendment No. 1 Assignments Refers to Public Health
  3/13/2018SenateAdded as Chief Co-Sponsor Sen. Mattie Hunter
  3/13/2018SenateAdded as Co-Sponsor Sen. Kimberly A. Lightford
  3/13/2018SenateAdded as Chief Co-Sponsor Sen. Emil Jones, III
  3/13/2018SenateAdded as Chief Co-Sponsor Sen. Iris Y. Martinez
  3/14/2018SenatePostponed - Public Health
  3/14/2018SenateSenate Committee Amendment No. 1 Postponed - Public Health
  3/14/2018SenateAdded as Co-Sponsor Sen. Cristina Castro
  4/6/2018SenateSenate Committee Amendment No. 2 Filed with Secretary by Sen. Jacqueline Y. Collins
  4/6/2018SenateSenate Committee Amendment No. 2 Referred to Assignments
  4/10/2018SenateSenate Committee Amendment No. 2 Assignments Refers to Public Health
  4/10/2018SenateSenate Committee Amendment No. 1 Postponed - Public Health
  4/10/2018SenateSenate Committee Amendment No. 2 Adopted
  4/11/2018SenateDo Pass as Amended Public Health; 006-001-000
  4/11/2018SenatePlaced on Calendar Order of 2nd Reading April 12, 2018
  4/13/2018SenateSenate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
  4/18/2018SenateSecond Reading
  4/18/2018SenatePlaced on Calendar Order of 3rd Reading April 19, 2018
  4/23/2018SenateThird Reading - Passed; 043-000-000
  4/23/2018HouseArrived in House
  4/23/2018HouseChief House Sponsor Rep. Kathleen Willis
  4/24/2018HouseFirst Reading
  4/24/2018HouseReferred to Rules Committee
  5/2/2018HouseAssigned to Human Services Committee
  5/16/2018HouseDo Pass / Short Debate Human Services Committee; 012-000-000
  5/17/2018HousePlaced on Calendar 2nd Reading - Short Debate
  5/17/2018HouseAdded Alternate Chief Co-Sponsor Rep. Litesa E. Wallace
  5/17/2018HouseAdded Alternate Chief Co-Sponsor Rep. Nick Sauer
  5/17/2018HouseAdded Alternate Chief Co-Sponsor Rep. Robyn Gabel
  5/17/2018HouseAdded Alternate Chief Co-Sponsor Rep. Laura Fine
  5/17/2018HouseAdded Alternate Co-Sponsor Rep. Stephanie A. Kifowit
  5/17/2018HouseAdded Alternate Co-Sponsor Rep. Lou Lang
  5/17/2018HouseAdded Alternate Co-Sponsor Rep. Nicholas K Smith
  5/17/2018HouseAdded Alternate Co-Sponsor Rep. Deb Conroy
  5/18/2018HouseSecond Reading - Short Debate
  5/18/2018HousePlaced on Calendar Order of 3rd Reading - Short Debate
  5/21/2018HouseThird Reading - Short Debate - Passed 101-000-000
  5/21/2018SenatePassed Both Houses
  6/19/2018SenateSent to the Governor
  6/27/2018SenateAdded as Co-Sponsor Sen. Thomas Cullerton
  8/3/2018SenateGovernor Approved
  8/3/2018SenateEffective Date January 1, 2019
  8/3/2018SenatePublic Act . . . . . . . . . 100-0723

Back To Top